|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2004-4-19
|
|
pubmed:abstractText |
Adults with chronic idiopathic thrombocytopenic purpura (ITP) in whom standard-dose corticosteroids and splenectomy have failed or who have contraindications to these therapies often require further treatment for life-threatening thrombocytopenia or bleeding. We studied whether danazol, an attenuated androgen, is useful in this setting.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0002-9343
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
116
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
590-4
|
|
pubmed:dateRevised |
2005-2-1
|
|
pubmed:meshHeading |
pubmed-meshheading:15093754-Adrenal Cortex Hormones,
pubmed-meshheading:15093754-Adult,
pubmed-meshheading:15093754-Aged,
pubmed-meshheading:15093754-Aged, 80 and over,
pubmed-meshheading:15093754-Chronic Disease,
pubmed-meshheading:15093754-Danazol,
pubmed-meshheading:15093754-Disease-Free Survival,
pubmed-meshheading:15093754-Estrogen Antagonists,
pubmed-meshheading:15093754-Female,
pubmed-meshheading:15093754-Follow-Up Studies,
pubmed-meshheading:15093754-Humans,
pubmed-meshheading:15093754-Male,
pubmed-meshheading:15093754-Middle Aged,
pubmed-meshheading:15093754-Prospective Studies,
pubmed-meshheading:15093754-Purpura, Thrombocytopenic, Idiopathic,
pubmed-meshheading:15093754-Splenectomy,
pubmed-meshheading:15093754-Time Factors
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Danazol therapy in patients with chronic idiopathic thrombocytopenic purpura: long-term results.
|
|
pubmed:affiliation |
Departments of Hematology and Oncology, Strasbourg, France.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
